This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Transfer Impedance in Cystic Fibrosis (Ztr)

This study is currently recruiting participants.
See Contacts and Locations
Verified July 2017 by Thomas Martin, Boston Children's Hospital
Sponsor:
Information provided by (Responsible Party):
Thomas Martin, Boston Children's Hospital
ClinicalTrials.gov Identifier:
NCT00743158
First received: August 27, 2008
Last updated: July 31, 2017
Last verified: July 2017
  Purpose
This study aims to determine whether respiratory system transfer impedance (Ztr) may fill an important clinical function by providing a reproducible, valid, and sensitive measure of airway obstruction in people with CF.

Condition
Cystic Fibrosis

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Transfer Impedance in Cystic Fibrosis (Ztr)

Resource links provided by NLM:


Further study details as provided by Thomas Martin, Boston Children's Hospital:

Estimated Enrollment: 40
Study Start Date: August 2008
  Eligibility

Ages Eligible for Study:   2 Years to 25 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Cystic Fibrosis Patients
Criteria

Inclusion Criteria:

  • Between the ages of 2 to 25 Confirmed diagnosis of Cystic Fibrosis

Exclusion Criteria:

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00743158

Locations
United States, Massachusetts
Childrens Hospital, Boston Recruiting
Boston, Massachusetts, United States, 02115
Contact: Lamia Momen, BA    617-355-6665    lamia.momen@childrens.harvard.edu   
Principal Investigator: Thomas R Martin, MD         
Sponsors and Collaborators
Boston Children’s Hospital
  More Information

Responsible Party: Thomas Martin, Assistant Professor of Pediatrics, Boston Children's Hospital
ClinicalTrials.gov Identifier: NCT00743158     History of Changes
Other Study ID Numbers: X08-01-0060
Study First Received: August 27, 2008
Last Updated: July 31, 2017

Keywords provided by Thomas Martin, Boston Children's Hospital:
ztr
transfer impedance
cystic fibrosis
pulmonary function test
pft

Additional relevant MeSH terms:
Fibrosis
Cystic Fibrosis
Pathologic Processes
Pancreatic Diseases
Digestive System Diseases
Lung Diseases
Respiratory Tract Diseases
Genetic Diseases, Inborn
Infant, Newborn, Diseases

ClinicalTrials.gov processed this record on August 18, 2017